Endovascular treatment for acute stroke

In this randomized trial of patients with acute stroke s/p t-PA, they were randomized to further endovascular treatment or no treatment; the trial was stopped early, as the 90 day Rankin and NIHSS scores were no different between the groups, nor was mortality. Currently, the use of endovascular treatment after t-PA has unproven benefit (abstract).

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment